|
Originally Posted by surgeonstone
(Post 16363516)
Not well
|
I've been dealing with rheumatoid arthritis for over 10 years, my specialist says that activity really helps, between bike riding and Enbrel, my issues (ankles, wrists, hands, some knees) are under control.
|
Originally Posted by surgeonstone
(Post 16363008)
Osteoarthritis is synonymous with degenerative arthritis. Motion, low impact exercise, NSAID's are all effective. Weight loss if overweight is critical (figure out the extra work/impact in a person 30 lbs overweight over a day of activity/walking- a non inconsiderable amount). When pain is unbearable in that it prevents effective sleep/activity then joint replacement is indicated and is quite wonderful.
Rheumatoid Arthritis is a much more serious condition with an autoimmune origin, more difficult to treat and often requiring more dangerous drugs ( methotrexate, Plaquinal, steroids ). you said it much better than I could have, thank you. |
Originally Posted by merlinextraligh
(Post 16361438)
Actually not. I've had rheumatoid arthristis since I was 8 years old. Both the medical advice I've received, as well as my experience is that staying active helps rather than hurts.
And cycling is an ideal way to keep moving because it's not weight bearing. Additionally to the extent that cycling helps in weight control, reducing the load on your joints it helps in that regard as well. Thus, people with arthritis should ride as much as they can tolerate. |
Originally Posted by rpenmanparker
(Post 16363468)
Thanks for the explanation. The term degenerative was confusing to me, because I thought it referred to the result of the arthritis as in the permanent joint swelling, etc. that occurs more commonly in the rheumatoid variety. But now I understand it refers to the cause of the arthritis, the gradual degeneration of the joint with age as imperfections develop rather than the autoimmune response. Or do I still have it screwed up?
|
Spin as fast as possible, and don't do any work - less resistance, the better, along with more movement, the better.
Take time to warm up before starting out. |
I think my condition is not classified as artritis yet but i will probably end up with that. I'll see another orthopedist on Monday to see the latest status. Today i felt a small locking on my right knee. There is no pain now though. Maybe the mixture of ginger, turmeric and cherry stem helped to alleviate the inflammation.
|
Originally Posted by phoebeisis
(Post 16364153)
Read the label on your NSAID
NSAID increase MI risk (aspirin is a NSAID but it generally isn't "considered" one-naproxen "might" be neutral in MI risk) the rest make you more likely to have a heart attack-so opiates can be a better option or add them to aspirin or naproxen The naproxen MI risk-still unsettled-FDA is unconvinced it doesn't increase risk-smallish study indicated it is "ok"-ibuprofen "might be nearly neutral" the rest are responsible for increased MI risk-"cause heart attacks" NSAID "cause" MIs Opiates cause addiction Tylenol is toxic and worthless The "easier on your stomach NSAID" are the highest risk ones Never a free lunch in respect to medications. In addition we should not overlook the use of topical anti-inflammatory drugs like Voltaren for arthritis. The dosage of such drugs is necessarily low compared to a systemic absorption of NSAIDs taken enterally or parenterally. Similarly the side effects of such drugs should be reduced compared to effective doses of systemically absorbed NSAIDs. The topical NSAIDs are very inconvenient, but they can be very attractive to those who cannot safely take NSAIDs by mouth. |
Argue with Lancet-these folks will tell you the risk level.
The new study, published in The Lancet, found that high doses of not only coxibs but also older-generation NSAIDs like ibuprofen (Advil) or diclofenac (Voltaren) were associated with heart disease risk. "For every 1,000 individuals with a moderate risk of heart disease allocated to one year of treatment with high-dose diclofenac or ibuprofen, about three would experience an avoidable heart attack of which one would be fatal," said a press statement accompanying the study. "In addition, all NSAIDs double the risk of heart failure and produce a 2-4 times increased risk of serious upper gastrointestinal complications such as bleeding ulcers," said the statement. A high dose of diclofenac is indicated as 150 milligrammes per day and of ibuprofen about 2,400 milligrams per day. "High doses are generally doses available only with a prescription," said Griffin. Read more: http://www.nydailynews.com/life-styl...#ixzz2ooMBzisy The OTC folks beat back the suggested labeling change-MI risks- so I was wrong suggesting you would find it on the label-my mistake. However-what i said-not one bit biased- "just the facts" according to our Limey friends. Oh-I never said NSAID shouldn't be used-I use them- use home made pepper cream also. My comment was in response to surgeonstone's blanket condemnation of opiates for "arthritic pain" |
Originally Posted by phoebeisis
(Post 16364531)
Argue with Lancet-these folks will tell you the risk level.
The new study, published in The Lancet, found that high doses of not only coxibs but also older-generation NSAIDs like ibuprofen (Advil) or diclofenac (Voltaren) were associated with heart disease risk. "For every 1,000 individuals with a moderate risk of heart disease allocated to one year of treatment with high-dose diclofenac or ibuprofen, about three would experience an avoidable heart attack of which one would be fatal," said a press statement accompanying the study. "In addition, all NSAIDs double the risk of heart failure and produce a 2-4 times increased risk of serious upper gastrointestinal complications such as bleeding ulcers," said the statement. A high dose of diclofenac is indicated as 150 milligrammes per day and of ibuprofen about 2,400 milligrams per day. "High doses are generally doses available only with a prescription," said Griffin. Read more: http://www.nydailynews.com/life-styl...#ixzz2ooMBzisy The OTC folks beat back the suggested labeling change-MI risks- so I was wrong suggesting you would find it on the label-my mistake. However-what i said-not one bit biased- "just the facts" according to our Limey friends. Oh-I never said NSAID shouldn't be used-I use them- use home made pepper cream also. My comment was in response to surgeonstone's blanket condemnation of opiates for "arthritic pain" http://www.thelancet.com/journals/la...370-1/abstract The conclusion of the study is that non-aspirin NSAIDs should not be used with the expectation if protection from serious cardiac episodes, but no mention is made of avoiding them due to their causation of such episodes. As I said the decision whether or not to use NSAIDs and which one to use is complex and personal, but blanket avoidance isn't automatically indicated. I don't think we are that so far apart. I just feel that many people who could be helped on balance by NSAID therapy are improperly frightened away from it by the sensational press the subject has received. |
Originally Posted by rpenmanparker
(Post 16364567)
You wouldn't have the original article would you? Newspaper reviews of medical articles are notoriously misleading. For example, what does "avoidable heart attack mean"? Specifically, does it mean avoidable by not taking an NSAID or avoidable by some other means? Here is an actual abstract of a study also published in the Lancet that suggests the rate of "cases of serious heart disease" is higher in non-aspirin NSAID users by 2-15% as compared to the general population in the age group under study.
http://www.thelancet.com/journals/la...370-1/abstract The conclusion of the study is that non-aspirin NSAIDs should not be used with the expectation if protection from serious cardiac episodes, but no mention is made of avoiding them due to their causation of such episodes. As I said the decision whether or not to use NSAIDs and which one to use is complex and personal, but blanket avoidance isn't automatically indicated. I don't think we are that so far apart. I just feel that many people who could be helped on balance by NSAID therapy are improperly frightened away from it by the sensational press the subject has received. LANCET BELOW Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials Coxib and traditional NSAID Trialists' (CNT) Collaboration† Summary Background The vascular and gastrointestinal effects of non-steroidal anti-inflammatory drugs (NSAIDs), including selective COX-2 inhibitors (coxibs) and traditional non-steroidal anti-inflammatory drugs (tNSAIDs), are not well characterised, particularly in patients at increased risk of vascular disease. We aimed to provide such information through meta-analyses of randomised trials. Methods We undertook meta-analyses of 280 trials of NSAIDs versus placebo (124 513 participants, 68 342 person-years) and 474 trials of one NSAID versus another NSAID (229 296 participants, 165 456 person-years). The main outcomes were major vascular events (non-fatal myocardial infarction, non-fatal stroke, or vascular death); major coronary events (non-fatal myocardial infarction or coronary death); stroke; mortality; heart failure; and upper gastrointestinal complications (perforation, obstruction, or bleed). Findings Major vascular events were increased by about a third by a coxib (rate ratio [RR] 1·37, 95% CI 1·14—1·66; p=0·0009) or diclofenac (1·41, 1·12—1·78; p=0·0036), chiefly due to an increase in major coronary events (coxibs 1·76, 1·31—2·37; p=0·0001; diclofenac 1·70, 1·19—2·41; p=0·0032). Ibuprofen also significantly increased major coronary events (2·22, 1·10—4·48; p=0·0253), but not major vascular events (1·44, 0·89—2·33). Compared with placebo, of 1000 patients allocated to a coxib or diclofenac for a year, three more had major vascular events, one of which was fatal. Naproxen did not significantly increase major vascular events (0·93, 0·69—1·27). Vascular death was increased significantly by coxibs (1·58, 99% CI 1·00—2·49; p=0·0103) and diclofenac (1·65, 0·95—2·85, p=0·0187), non-significantly by ibuprofen (1·90, 0·56—6·41; p=0·17), but not by naproxen (1·08, 0·48—2·47, p=0·80). The proportional effects on major vascular events were independent of baseline characteristics, including vascular risk. Heart failure risk was roughly doubled by all NSAIDs. All NSAID regimens increased upper gastrointestinal complications (coxibs 1·81, 1·17—2·81, p=0·0070; diclofenac 1·89, 1·16—3·09, p=0·0106; ibuprofen 3·97, 2·22—7·10, p<0·0001; and naproxen 4·22, 2·71—6·56, p<0·0001). Interpretation The vascular risks of high-dose diclofenac, and possibly ibuprofen, are comparable to coxibs, whereas high-dose naproxen is associated with less vascular risk than other NSAIDs. Although NSAIDs increase vascular and gastrointestinal risks, the size of these risks can be predicted, which could help guide clinical decision making. ME AGAIN- my whole point was objecting to a blanket condemnation of opiates for osteoarthritis- USA medicine swings back and forth-20-30 year cycles-on that point- Opiates keep making comebacks because the alternatives-have problems- I take naproxen for joint pain-works great.Sure as hell wouldn't take ANY of the rest. |
Originally Posted by phoebeisis
(Post 16365371)
Here is the actual summary from Lancet ...
http://www.bikeforums.net/faq.php?fa...ghted_material |
Originally Posted by phoebeisis
(Post 16365371)
Here is the actual summary from Lancet-bottom line-all but naproxen "cause" MIs-this was with high dose use of course-it is reasonable to assume a dose effect-take more-more MIs-take less fewer MIs- TAKE NAPROXEN- avoid the rest
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials Coxib and traditional NSAID Trialists' (CNT) Collaboration† Summary Background The vascular and gastrointestinal effects of non-steroidal anti-inflammatory drugs (NSAIDs), including selective COX-2 inhibitors (coxibs) and traditional non-steroidal anti-inflammatory drugs (tNSAIDs), are not well characterised, particularly in patients at increased risk of vascular disease. We aimed to provide such information through meta-analyses of randomised trials. Methods We undertook meta-analyses of 280 trials of NSAIDs versus placebo (124 513 participants, 68 342 person-years) and 474 trials of one NSAID versus another NSAID (229 296 participants, 165 456 person-years). The main outcomes were major vascular events (non-fatal myocardial infarction, non-fatal stroke, or vascular death); major coronary events (non-fatal myocardial infarction or coronary death); stroke; mortality; heart failure; and upper gastrointestinal complications (perforation, obstruction, or bleed). Findings Major vascular events were increased by about a third by a coxib (rate ratio [RR] 1·37, 95% CI 1·14—1·66; p=0·0009) or diclofenac (1·41, 1·12—1·78; p=0·0036), chiefly due to an increase in major coronary events (coxibs 1·76, 1·31—2·37; p=0·0001; diclofenac 1·70, 1·19—2·41; p=0·0032). Ibuprofen also significantly increased major coronary events (2·22, 1·10—4·48; p=0·0253), but not major vascular events (1·44, 0·89—2·33). Compared with placebo, of 1000 patients allocated to a coxib or diclofenac for a year, three more had major vascular events, one of which was fatal. Naproxen did not significantly increase major vascular events (0·93, 0·69—1·27). Vascular death was increased significantly by coxibs (1·58, 99% CI 1·00—2·49; p=0·0103) and diclofenac (1·65, 0·95—2·85, p=0·0187), non-significantly by ibuprofen (1·90, 0·56—6·41; p=0·17), but not by naproxen (1·08, 0·48—2·47, p=0·80). The proportional effects on major vascular events were independent of baseline characteristics, including vascular risk. Heart failure risk was roughly doubled by all NSAIDs. All NSAID regimens increased upper gastrointestinal complications (coxibs 1·81, 1·17—2·81, p=0·0070; diclofenac 1·89, 1·16—3·09, p=0·0106; ibuprofen 3·97, 2·22—7·10, p<0·0001; and naproxen 4·22, 2·71—6·56, p<0·0001). Interpretation The vascular risks of high-dose diclofenac, and possibly ibuprofen, are comparable to coxibs, whereas high-dose naproxen is associated with less vascular risk than other NSAIDs. Although NSAIDs increase vascular and gastrointestinal risks, the size of these risks can be predicted, which could help guide clinical decision making. Funding UK Medical Research Council and British Heart Foundation. This article is made available free of charge, as a service to our users. Please login to access the full article, or register if you do not yet have a username and password. Already Registered? Please Login Username: Password: Forgotten Username or Password? Remember me on this computer until I logout New to TheLancet.com? TheLancet.com is the online home of: The Lancet The Lancet Diabetes & Endocrinology The Lancet Infectious Diseases The Lancet Neurology The Lancet Oncology The Lancet Respiratory Medicine Please register to access selected articles for free, personalize and interact with this site. Registration is free, takes no more than two minutes, and offers you many benefits. † Collaborators are listed at the end of the report Access this article on ScienceDirect Article Options Summary Full Text PDF (494 KB) Cited by in Scopus (4) Printer Friendly Version Download images Request permission Export Citation Create Citation Alert Linked Articles Comment High-dose non-steroidal anti-inflammatories: painful choices Editorial Advances in autoimmune rheumatic diseases Other Articles of Interest Comment A coxib a day won't keep the doctor away The Lancet Oncology Commission Planning cancer control in Latin America and the Caribbean The Lancet Commissions Global health 2035: a world converging within a generation Health Policy Universal health coverage in Turkey: enhancement of equity Articles Non-invasive risk scores for prediction of type 2 diabetes (EPIC-InterAct): a validation of existing models Bookmark Delicious Digg ****** StumbleUpon |
This study was HIGH DOSE.
A low dose of ibuprofen would be maybe 800mg/d this study was 2400mg- a max dose would be 3200/d Was the earlier study with "all doses"? There is almost always a dose effect on "side effects" (except allergies)-take more have more problems-take less fewer problems. |
Topically??- probably ZERO detectable MI or stomach risk.
Blood levels are sooooo low-no problems- Yeah I wouldn't worry one bit about topical application. Oh-slight aside-indications that various NSAID cause problems with some ACE inhibitors for HBP-making them less effective and some indications they can decrease kidney function with chronic use. |
Originally Posted by Machka
(Post 16365418)
A suggestion ... you might want to read the link below, and then go in and tidy up what you've posted. :)
http://www.bikeforums.net/faq.php?fa...ghted_material |
Originally Posted by phoebeisis
(Post 16365496)
Topically??- probably ZERO detectable MI or stomach risk.
Blood levels are sooooo low-no problems- Yeah I wouldn't worry one bit about topical application. Oh-slight aside-indications that various NSAID cause problems with some ACE inhibitors for HBP-making them less effective and some indications they can decrease kidney function with chronic use. I think the other good news regarding the topical NSAID application is you can continue an aspirin regimen along with the non-aspirin NSAID without either unduly stressing the GI tract or losing any of the protective effect. I am just assuming that, but it makes sense if the systemic absorption of the topical NSAID is really so low. |
Relative to taking it by mouth-topical absorption of most drugs-minimal.
Takes "lots of doing" and lots of time and high lipid solubility to get various estrogen preps properly absorbed-probably only 2-3% of estrogen in various patches is absorbed-and that takes 4 days-high lipid solubility-perfect contact Now "some" of your topical NSAID gets absorbed-but blood levels would be much much lower than oral-probably can find a study showing just that-bet peak blood level 1/100 to 1/10,000 peak level of oral dose- Yes-I take lisinopril also- cheap safe effective hard to beat- maybe it makes my nose run-but no cough And good evidence that NSAID decrease renal artery flow-transient of course-(pretty sure I have noticed that I get up less at night(63yo) when I take a naproxen in the late evening-anecdote of course,but...) The speculation is the decreased renal artery blood flow-triggers increase in BP(maybe pulse too) and that-along with the "not aspirin effect(sorta opposite effect) on platelet adhesion" is the WHY of the increased MI risk from NSAID |
Originally Posted by phoebeisis
(Post 16365861)
Relative to taking it by mouth-topical absorption of most drugs-minimal.
Takes "lots of doing" and lots of time and high lipid solubility to get various estrogen preps properly absorbed-probably only 2-3% of estrogen in various patches is absorbed-and that takes 4 days-high lipid solubility-perfect contact Now "some" of your topical NSAID gets absorbed-but blood levels would be much much lower than oral-probably can find a study showing just that-bet peak blood level 1/100 to 1/10,000 peak level of oral dose- Yes-I take lisinopril also- cheap safe effective hard to beat- maybe it makes my nose run-but no cough And good evidence that NSAID decrease renal artery flow-transient of course-(pretty sure I have noticed that I get up less at night(63yo) when I take a naproxen in the late evening-anecdote of course,but...) The speculation is the decreased renal artery blood flow-triggers increase in BP(maybe pulse too) and that-along with the "not aspirin effect(sorta opposite effect) on platelet adhesion" is the WHY of the increased MI risk from NSAID |
Right
I'm in River Ridge now-between harahan and kenner -lived off Tulane then on State street near the river then off Claiborne near Broadway -moved to River Ridge 25 years ago I'm almost exactly one mile from the river- makes rides nice-ride down to levee-climb levee 15 times-ride home Nice day today-a bit miserable yesterday.Did you ride today? Now the saints-hmmmm- never an optimist when it comes to the saints-but these saints sure aren't "the old saints" |
Originally Posted by phoebeisis
(Post 16366196)
Right
I'm in River Ridge now-between harahan and kenner -lived off Tulane then on State street near the river then off Claiborne near Broadway -moved to River Ridge 25 years ago I'm almost exactly one mile from the river- makes rides nice-ride down to levee-climb levee 15 times-ride home Nice day today-a bit miserable yesterday.Did you ride today? Now the saints-hmmmm- never an optimist when it comes to the saints-but these saints sure aren't "the old saints" Quite a difference. |
Originally Posted by phoebeisis
(Post 16364531)
Argue with Lancet-these folks will tell you the risk level.
The new study, published in The Lancet, found that high doses of not only coxibs but also older-generation NSAIDs like ibuprofen (Advil) or diclofenac (Voltaren) were associated with heart disease risk. "For every 1,000 individuals with a moderate risk of heart disease allocated to one year of treatment with high-dose diclofenac or ibuprofen, about three would experience an avoidable heart attack of which one would be fatal," said a press statement accompanying the study. "In addition, all NSAIDs double the risk of heart failure and produce a 2-4 times increased risk of serious upper gastrointestinal complications such as bleeding ulcers," said the statement. A high dose of diclofenac is indicated as 150 milligrammes per day and of ibuprofen about 2,400 milligrams per day. "High doses are generally doses available only with a prescription," said Griffin. Read more: http://www.nydailynews.com/life-styl...#ixzz2ooMBzisy The OTC folks beat back the suggested labeling change-MI risks- so I was wrong suggesting you would find it on the label-my mistake. However-what i said-not one bit biased- "just the facts" according to our Limey friends. Oh-I never said NSAID shouldn't be used-I use them- use home made pepper cream also. My comment was in response to surgeonstone's blanket condemnation of opiates for "arthritic pain" With regards to NSAID use I agree with the Lancet entirely. There are side effects and one must, with the help of a doc, do some risk assessment. is the risk of a fatal heart attack less or more than the risk of a fatal pulmonary embolism secondary to a DVT post op hip replacement. For me, I have no history of heart disease in the family, no history of hypertension nor a history of elevated lipids. I thus rationalize the use and risk of NSAID's as being reasonable for now. Were I suffering from hypertension, were I at a significant familial risk of MI, I might very well reduce or avoid the NSAID's and go for reparative surgery earlier. It's all a risk relevant crap shoot and you can never know for sure the outcome...... except for one of the topics discussed above. And that is that repeated opiate use for chronic pain will cause addiction and is, IMHO, malpractice. Now there are some situations where even that state can't be avoided, the patient with severe RA that can't move, that can't get surgery, that quite literally has no other options. In that situation even the "malpractice" option may be needed but all concerned need to completely understand the path they are embarking on. An interesting side note, we in America comprise 4.28% of the worlds population and consume 70 percent of the worlds narcotics. |
I thought aspirin is supposed to reduce the risk of heart attacks?
|
surgeonstone, thanks that is a very helpful treatment of the issue. Appreciated.
|
Originally Posted by rpenmanparker
(Post 16366497)
surgeonstone, thanks that is a very helpful treatment of the issue. Appreciated.
|
| All times are GMT -6. The time now is 02:56 AM. |
Copyright © 2024 MH Sub I, LLC dba Internet Brands. All rights reserved. Use of this site indicates your consent to the Terms of Use.